The interface between adaptive and innate neutralisation of virus entry: competition, addition or synergy?

QR Code

The interface between adaptive and innate neutralisation of virus entry: competition, addition or synergy?

A complex interplay exists between the innate and adaptive immune systems when responding to viral infections. In particular, complement activity is required to both directly and indirectly eradicate virus infection. The aim of this study was to identify the effect of complement on antibody-mediated...

Full description

Bibliographic Details
Main Author:	Wartnaby, Sophie R.
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2023
Subjects:	Hepatitis C; Immunoglobulins; Monoclonal antibodies
Online Access:	https://eprints.nottingham.ac.uk/73998/

Similar Items

Generation of human monoclonal antibodies: the development of methods to identify and isolate neutralising antibodies targeted to Ebolavirus from peripheral blood
by: Bailey, Graham D.
Published: (2017)

Localization of the antigenic sites of Newcastle disease virus nucleocapsid using a panel of monoclonal antibodies
by: Ahmad-Raus, Raha, et al.
Published: (2009)

Production, characterization and scaling up of monoclonal antibodies against neuraminidase glycoprotein of avian influenza virus subtype H9N2
by: Abdelaziz Fadul, Sana Awad
Published: (2011)

Development of monoclonal antibodies against porcine blood for detection in fish-based products
by: Raja Nhari, Raja Mohd Hafidz
Published: (2017)

Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration
by: Negm, Ola H., et al.
Published: (2017)

Penghasilan Hibridoma yang Merembeskan Antibodi Monoklon Terhadap Hormon Tiroksin (T4)
by: Yahya, Siti Romlah
Published: (1994)

Production and evaluation of monoclonal antibody against Strongyloides ratti
by: Aliyu, Mahmuda
Published: (2017)

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
by: Mesalam, Ahmed Atef, et al.
Published: (2018)

Penghasilan Sel Hibridoma Menggunakan Teknik Elektrofusion
by: Hamid, Muhajir
Published: (1995)

Characterization of M1A2 monoclonal antibody and in vitro cytotoxicity assessment
by: Bashokouh, Fatemeh
Published: (2012)

A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
by: Negm, Ola H., et al.
Published: (2018)

Development of dye affinity adsorbents for recovery of polyclonal anti-hepatitis B core antigen immunoglobulin G
by: Wongchuphan, Rattana
Published: (2010)

Purification and characterization of polyclonal anti-hepatitis B core antigen immunoglobulin G from rabbit serum
by: Sayed Hitam, Sharifah Mariam
Published: (2016)

The generation and characterisation of anti-glycan monoclonal antibodies
by: Chua, Jia Xin
Published: (2017)

Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity
by: Tey, Beng Ti, et al.
Published: (2004)

Optimization of serum free medium for the production of humanized anti-cea monoclonal antibody.
by: Ab Latif, Nurzila
Published: (2011)

Risk factors for hepatitis c virus infection among adult patients at a public hospital in Kedah, Malaysia
by: Mohd Suan, Mohd Azri
Published: (2019)

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
by: Hamed, Mohamed R., et al.
Published: (2014)

Effectiveness of an education intervention on Hepatitis C treatment adherence among Libyan patients in a medical center in Tripoli
by: Adam, Samia Ibrahim Mohamed
Published: (2018)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

An investigation into the vaccine responsiveness of multiple sclerosis patients being treated with Ocrelizumab
by: Thomas, Niamh
Published: (2024)

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
by: Desombere, Isabelle, et al.
Published: (2017)

The future of multiple sclerosis treatments
by: Coclitu, Catalina, et al.
Published: (2016)

Predicting response to monoclonal antibody in severe asthma
by: Pang, Yik Lam
Published: (2022)

A monoclonal antibody raised against a thermo-stabilised β1-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of 1- adrenoceptors expressed in stable cell lines
by: Soave, Mark, et al.
Published: (2018)

Investigation of Hepatitis B virus entry mechanism
by: Raymond, Chidinma
Published: (2022)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Production, Establishment and Characterisation of Monoclonal Antibody Against Breast Cancer Cell Line (Mcf-7)
by: Ong, Boo Kean
Published: (1995)

Novel entry pathways for Hepatitis B virus
by: Parmar, Devan
Published: (2023)

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules
by: Rees, Jennifer, et al.
Published: (2016)

The effects of the human innate pattern recognition receptor L-ficolin and its variants against Hepatitis C virus infection
by: Mason, Christopher Paul
Published: (2019)

The Influence of MHC and Immunoglobulins A and E on Host Resistance to Gastrointestinal Nematodes in Sheep
by: Lee, C., et al.
Published: (2011)

High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease
by: Hedegaard, Ditte L., et al.
Published: (2017)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)

Development of IgE microarray assays for classification of allergic individuals
by: Hamed, Aljali
Published: (2016)

Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment
by: Fraser, S., et al.
Published: (2011)

Hepatitis C treatment - better outcomes through partner support
by: Chapman, Fleur, et al.
Published: (2012)

Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus recover genotype cross-reactive neutralising antibodies to HCV during antiretroviral therapy
by: Lee, S., et al.
Published: (2014)

Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with advanced and primary colorectal cancer
by: Maxwell-Armstrong, Charles Alan
Published: (1998)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)